Bruce R. Zetter

Chairman, Scientific Advisory Board at Syndevrx

Dr. Zetter is an international leader in cancer research who has served as a consultant or scientific advisory board member with over 30 biotechnology and pharmaceutical companies.

Dr. Zetter has been the Charles Nowiszewski Professor in the departments of Cell Biology and Surgery at Harvard Medical School since 2000 and conducts research at Boston Children’s Hospital, where he served as vice president of research and chief scientific officer from 2004 to 2008. His numerous national and international awards for his work in the field of cancer research include a Faculty Research Award from the American Cancer Society, a Creativity Award from the Prostate Cancer Foundation and two MERIT awards from the U.S. National Cancer Institute.

In addition to publishing 150+ research papers, Dr. Zetter has served on the editorial boards of 11 peer-reviewed journals and given 300+ lectures to universities, conferences and businesses. He has also served as an expert witness for the U.S. Senate Cancer Coalition hearings in Washington and in court cases involving health and biotechnology.

Dr. Zetter received his Ph.D. from the University of Rhode Island and completed postdoctoral fellowships at MIT and the Salk Institute in San Diego.

Timeline

  • Chairman, Scientific Advisory Board

    Current role